A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer.
Marc A FurrerNathan PapaSandro LuetolfBeat RothMarcus CumberbatchMihai Dorin VartolomeiBenjamin C ThomasHarriet C ThoenyRoland SeilerGeorge N ThalmannBernhard KissPublished in: BJU international (2021)
Re-staging of muscle-invasive bladder cancer after two cycles of NAC offers little additional information, rarely changes patient management, and may therefore be omitted, whereas re-staging after completion of NAC by CT is a strong predictor of overall survival.
Keyphrases
- neoadjuvant chemotherapy
- muscle invasive bladder cancer
- lymph node
- transcription factor
- sentinel lymph node
- locally advanced
- pet ct
- computed tomography
- case report
- genome wide analysis
- image quality
- dual energy
- health information
- contrast enhanced
- healthcare
- positron emission tomography
- free survival
- magnetic resonance imaging
- radiation therapy
- social media